By Rana — Editor, Elite Era Trends

Anthropic, the company behind the Claude chatbot, is reported to begin the final sales pitch for its stock market listing this week. The catch is the price tag: investors are pushing the valuation far below the roughly $2 trillion figure discussed only weeks ago, and the company has still not confirmed a single date in public.

This is one of the biggest listings ever attempted, and it is arriving as the market for AI stocks turns sharply colder.

What an IPO roadshow actually is

An IPO roadshow is the sales tour a company runs before its shares first trade publicly. Senior executives, usually the chief executive and the chief financial officer, travel to meet the big institutional investors — pension funds, mutual funds, sovereign wealth funds and large asset managers — and make the case for buying in.

The meetings are not open to the public. Investors ask hard questions about revenue, growth, costs and competition, and then they tell the banks running the deal how much they are willing to pay. Those conversations decide the IPO price: the price at which the first shares are sold. Once that price is set, the shares start trading, and the price can move up or down freely from there.

For a company of Anthropic’s size, the roadshow is the moment the valuation stops being a negotiating position and becomes a number the market has to accept.

What is reported — and what is confirmed

The roadshow is reported to start in the week of 9 November 2026, according to IFR, Reuters and The Information. Pricing is reported to follow the week after, with a first day of trading aimed at about 20 November, before Thanksgiving on 26 November 2026.

It is important to be clear about the status of those dates: Anthropic has not confirmed any of them. The amended S-1 filing the company submitted on 2 November still contains no price range, no share count and no listing date. The dates above are what reporters say the company is planning, not what the company has announced.

The Financial Times reported on 6 November that Anthropic still plans to list before Thanksgiving, raising $80–100 billion at a $1.25–1.75 trillion valuation.

The valuation slide, in numbers

The most striking part of this story is how far the valuation has fallen in a matter of weeks.

When	Reported valuation	Change from ~$2 trillion
September–October 2026	About $2 trillion discussed	—
Early November 2026	$1.5–1.6 trillion demanded by investors (WSJ / Reuters)	−20% to −25%
6 November 2026	$1.2–1.3 trillion discussed (Bloomberg)	−35% to −40%
5 November 2026	About $1 trillion suggested by one investor (WSJ)	−50%
6 November 2026	$1.25–1.75 trillion, raising $80–100 billion (Financial Times)	−12.5% to −37.5%

Worked example: the valuation drops, in percent

From $2 trillion to $1.5 trillion: ($1.5T − $2T) ÷ $2T = −25%
From $2 trillion to $1.3 trillion: ($1.3T − $2T) ÷ $2T = −35%
From $2 trillion to $1.2 trillion: ($1.2T − $2T) ÷ $2T = −40%
From $2 trillion to $1 trillion: ($1T − $2T) ÷ $2T = −50%

The lowest figure reported would halve the company’s value versus a few weeks earlier.

The amount of money a company raises in an IPO is only meaningful next to the valuation. A bigger raise at a lower valuation sells a larger slice of the company.

At a $1.25 trillion valuation, an $80 billion raise is $80B ÷ $1,250B = 6.4% of the company
At a $2 trillion valuation, a $100 billion raise is $100B ÷ $2,000B = 5.0% of the company

So the reported plan hands new investors a bigger share of Anthropic than a $100 billion raise at $2 trillion would.

Why investors pushed back

The pushback has two causes. The first is the market. On 5 November, the S&P 500 fell 4.4% in a single day, and the Nasdaq entered correction territory — a drop of 10% or more from its recent peak. When the whole market is falling, investors get cautious about paying top prices for new listings.

The second is the company itself. Anthropic is growing extremely fast, but it is still losing money, and it has enormous spending commitments ahead of it. Investors who were willing to discuss a $2 trillion valuation in a rising market are now asking whether the numbers support it.

There is a parallel worth noting. OpenAI, Anthropic’s biggest rival, closed an $11 billion first tranche of new funding on 6 November at a $1.25 trillion valuation — a smaller raise than originally planned. We covered that OpenAI fundraise in detail. Two of the biggest names in AI are being repriced downward at the same time, which suggests a market-wide reassessment.

What the S-1 numbers actually show

Anthropic filed its public S-1 — the document a company must file before listing in the United States — on 26 October 2026, and amended it on 2 November. The shares will trade on the Nasdaq Global Select Market under the ticker ANT, and Goldman Sachs and Morgan Stanley lead a 22-bank underwriting syndicate. For the full breakdown, see our Anthropic S-1 explainer.

The headline figures are remarkable:

First-half 2026 revenue: $16.3 billion
Third-quarter 2026 revenue: $16.96 billion — up 47% from the second quarter’s $11.6 billion, and up 1,127% year over year
Third-quarter operating loss: $567 million

But the loss matters too. Anthropic is not yet profitable on an operating basis, and the $567 million third-quarter operating loss shows that growth is being bought with heavy spending. The company also has huge commitments: Broadcom will lend Anthropic up to $42 billion, and a Japanese filing shows a sale of up to $3.5 billion of shares in Japan.

Worked example: annualising the third quarter

A common way to size up a fast-growing company is to take one quarter’s revenue and multiply it by four. This is simple annualisation, not a forecast — it assumes the next three quarters look like the last one, which is almost certainly wrong for a company growing this fast.

$16.96 billion × 4 = $67.84 billion, or roughly $67.8 billion of annualised revenue
At a $1.25 trillion valuation, that implies a rough price-to-sales multiple of $1,250B ÷ $67.84B = about 18 times annualised third-quarter revenue

That is rough maths — the real figure depends on how fast revenue keeps growing and on the valuation the IPO actually prices at. But it shows why the valuation debate is so sharp: at $1.25 trillion, investors would be paying about 18 times a full year of revenue at the current run rate, against about 29 times at $2 trillion.

The market backdrop

The roadshow is reported to start in the worst possible week for it. The 5 November selloff — the S&P 500 down 4.4%, the Nasdaq in correction — was the kind of day that makes investors reconsider every new commitment. Reuters reported on 6 November that investors doubt a November listing is still feasible at all.

A Kalshi contract on an Anthropic IPO happening before 1 December traded at 70 cents on 8 November, down from 90 cents on 6 November. Traders who were near-certain of a November listing two days earlier have become noticeably less sure.

None of this means the IPO will fail. It means the timing is genuinely uncertain, and a delay — pushing the listing into December or later — is a real possibility. The Financial Times’ 6 November report that Anthropic still plans to list before Thanksgiving is the counterweight: the company, as far as reporters can tell, has not given up on November yet.

Competition is intensifying too: Mistral’s Large 4 licence changes and Google’s Gemini 4 Carbon launch show rivals moving fast just as the funding climate tightens.

What happens next

If the reported timetable holds:

Roadshow week (reported, week of 9 November): executives meet institutional investors and make the case for the shares.
Pricing week (reported, the following week): based on the orders the roadshow generates, the banks set the IPO price and the number of shares to be sold.
First trade (reported, about 20 November): the shares begin trading on the Nasdaq under the ticker ANT, and the market price is set by buyers and sellers from that point on.
Possible delay: if investor demand is weak, or if the market falls further, the company could push the listing back — Reuters reported on 6 November that some investors already doubt a November listing is feasible.

Watch the price the deal actually gets done at: a listing at $1.25 trillion would still be one of the largest IPOs in history.

What it means for Claude users

For Claude users, the honest answer is: probably very little, at least at first. An IPO changes who owns a company, not what its product does. Claude’s features, pricing and availability are decided by the company’s product and business teams, and a listing does not by itself change any of those.

Over a longer period, a public listing does change the pressures on a company. Public companies report their results every quarter, and shareholders can push for growth and profitability. That could eventually affect how Claude is priced or developed — but that is a slow process, and nothing in the S-1 suggests an immediate change for users. AI companies do adjust their products as their businesses mature, as the recent ChatGPT and Codex shared usage allowance changes at OpenAI show.

What it means for regular readers

Regular readers cannot buy Anthropic shares at the IPO price. IPO shares are allocated to institutional investors first — the pension funds and asset managers who attend the roadshow. The public buys shares once trading starts, at whatever price the market sets on the day.

If you are interested in the company, the practical steps are simple: wait for the listing, check the ticker ANT on the Nasdaq, and remember that the first day of trading is often volatile.

This article is not investment advice. If you are considering investing, speak to a qualified financial adviser and do your own research.

Checked against reporting from Reuters, Bloomberg, the Financial Times and the Wall Street Journal on 9 November 2026; Anthropic has not confirmed the roadshow dates.

Frequently asked questions

What is an IPO roadshow?

An IPO roadshow is the sales tour a company runs before its shares first trade publicly. Executives meet large institutional investors such as pension funds and asset managers, answer questions about revenue, costs and competition, and gauge how much those investors are willing to pay. The feedback helps the banks running the deal set the IPO price.

When is Anthropic’s IPO?

Anthropic’s IPO is reported to be timed for a first trade at about 20 November 2026, with the roadshow reported to start in the week of 9 November and pricing reported for the following week. Anthropic has not confirmed any of these dates, and the amended S-1 filed on 2 November contains no price range, share count or listing date.

What valuation is Anthropic seeking?

Anthropic is reported to be seeking a valuation of $1.25–1.75 trillion, raising $80–100 billion, according to the Financial Times on 6 November 2026. That is far below the roughly $2 trillion discussed in September and October. Bloomberg reported $1.2–1.3 trillion discussed on 6 November, while the Wall Street Journal reported on 5 November that one investor suggested about $1 trillion.

What did Anthropic’s S-1 filing show?

Anthropic’s S-1 filing showed first-half 2026 revenue of $16.3 billion and third-quarter revenue of $16.96 billion, up 47% from the second quarter’s $11.6 billion and up 1,127% year over year. The third quarter also showed an operating loss of $567 million, so the company is growing extremely fast but is not yet profitable. The filing also set the last private valuation at $965 billion, from the Series H round on 28 May 2026.

Can regular investors buy Anthropic (ANT) shares?

Regular investors cannot buy Anthropic shares at the IPO price, because IPO shares are allocated to institutional investors first. Once the shares start trading on the Nasdaq under the ticker ANT, anyone with a brokerage account can buy them at the market price, which may be above or below the IPO price. The first day of trading is often volatile, and this article is not investment advice.

What does the IPO mean for Claude users?

The IPO is likely to mean very little for Claude users in the short term, because a listing changes who owns the company, not what the product does. Claude’s features, pricing and availability are product decisions, and nothing in the S-1 filing suggests an immediate change. Over a longer period, being a public company brings quarterly reporting and shareholder pressure for growth and profitability, which could eventually affect product decisions, but that is a slow process.

Sources

Reuters, 6 November 2026 (roadshow timing, investor doubts on a November listing, 5 November selloff)
Bloomberg, 6 November 2026 ($1.2–1.3 trillion valuation discussed)
Financial Times, 6 November 2026 (listing before Thanksgiving; $80–100 billion raise at $1.25–1.75 trillion)
Wall Street Journal, 5 November 2026 ($1.5–1.6 trillion demanded by investors; one investor suggesting about $1 trillion)
The Information, 6 November 2026 (roadshow timing)
Anthropic S-1 and amended S-1 filings, 26 October and 2 November 2026 (revenue, operating loss, ticker ANT, underwriters, Broadcom facility)
PYMNTS, 9 November 2026 — OpenAI valuation hits $1.25 trillion in new funding round
Anthropic newsroom

By Rana — Editor, Elite Era Trends

Rana — Editor, Elite Era Trends

Rana is the editor of Elite Era Trends, where he explains Medicare, Social Security and AI news for US readers in plain language — costs, deadlines and plan choices, checked against official sources.

Anthropic’s IPO Roadshow Starts This Week — at a Much Lower Valuation Than Planned

In this article